Dr. Reddy’s Appoints Akhil Ravi as Head API and Services
Dr Reddys Laboratories Ltd · Change in Management · 24 Oct 2026, 12:12 am
Dr. Reddy’s Appoints Akhil Ravi as Head API and Services Dr. Reddy’s Laboratories approved the appointment of Akhil Ravi as Head API and Services, designated as Senior Management Personnel and inducted into the Management Council, effective 13th Nov'26. Ravi, who joined the company in 2018 and has nearly 19 years of industry experience, will continue leading operations at wholly owned subsidiary Aurigene Pharmaceutical Services Ltd. as CEO. He is classified as a related party, being the son-in-law of Co-Chairman and Managing Director G V Prasad.
Original exchange filing (PDF)
More announcements from Dr Reddys Laboratories Ltd
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 · 14 Nov 2026
- Intimation of Analyst meet · 11 Nov 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 · 05 Nov 2026
- Allotment of Employee Stock options · 04 Nov 2026
- Clarification - Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 · 04 Nov 2026
- The Exchange has sought Clarification from Dr Reddys Laboratories Ltd with reference to the media report appearing on https://www.firstpost.com dated November 03, 2026 (Link : https://www.firstpost.com/business/indias-dr-reddys-gets-us-nod-for-40-generic-hiv-prevention-shot-for-120-poorer-countries-14057224.html) .... · 03 Nov 2026
- Transcript of Earnings call · 30 Oct 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 · 28 Oct 2026
